A detailed history of Y Intercept (Hong Kong) LTD transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 14,809 shares of AMLX stock, worth $48,573. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,809
Holding current value
$48,573
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$2.94 - $7.03 $43,538 - $104,107
14,809 New
14,809 $55,000
Q2 2024

Aug 14, 2024

SELL
$1.62 - $2.71 $361,927 - $605,446
-223,412 Reduced 65.42%
118,105 $224,000
Q1 2024

May 10, 2024

BUY
$2.71 - $19.57 $792,168 - $5.72 Million
292,313 Added 594.08%
341,517 $969,000
Q4 2023

Feb 13, 2024

BUY
$12.07 - $18.46 $593,892 - $908,305
49,204 New
49,204 $724,000

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $192M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.